How this Nasdaq-U.K.-listed Chinese biotech is revolutionizing cancer treatment
September 17, 2020 at 12:55 PM EDT
Chi-Med has been granted three U.S. Food and Drug Administration Fast Track Designations for its cancer drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|